文献速递肝病消化道肿瘤与早癌

血清细胞因子水平与直接抗病毒药物治疗丙型肝炎病毒感染患者发生肝细胞癌相关

Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting Antivirals.
PubMed 文献 · Gastroenterology · 2017-11-02

研究评估接受直接抗病毒药物(DAA)治疗的丙型肝炎病毒(HCV)感染患者治疗前、中、后血清免疫介质水平,以识别肝细胞癌(HCC)风险。纳入13例治疗后18个月内发生HCC的患者(3例复发,10例新发)和10例未发生HCC的对照。治疗前12种免疫介质水平在后来发生新发HCC的患者中显著高于对照,其中9种细胞因子组合(MIG、IL22、TRAIL、APRIL、VEGF、IL3、TWEAK、SCF、IL21)识别新发HCC的AUC值高于0.8。

要点

  • 治疗前血清12种免疫介质水平在新发HCC患者中显著高于对照。
  • 9种细胞因子组合识别新发HCC的AUC值高于0.8。
  • DAA治疗期间炎症细胞因子水平变化可能提供HCV致癌及DAA影响的信息。

核心结论

  • 血清细胞因子水平与接受DAA治疗的HCV感染患者发生HCC相关,治疗前9种细胞因子组合可识别新发HCC且AUC值高于0.8。

研究设计与样本

  • 研究纳入13例DAA治疗后18个月内发生HCC的患者(3例HCC复发,10例新发HCC)和10例至少24个月内未发生HCC的对照(中位随访26个月)。

主要发现

  • 治疗前血清12种免疫介质(细胞因子、生长因子和凋亡标志物)水平在后来发生新发HCC的患者中显著高于对照。
  • 治疗前9种细胞因子组合(MIG、IL22、TRAIL、APRIL、VEGF、IL3、TWEAK、SCF、IL21)识别新发HCC的AUC值高于0.8。
  • DAA治疗期间炎症细胞因子水平变化的进一步分析提供了HCV诱导致癌及DAA影响的重要信息。

关键数值与推荐

  • 治疗前9种细胞因子组合识别新发HCC的AUC值高于0.8。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Concern has arisen about the development of hepatocellular carcinoma (HCC) in patients with hepatitis C virus (HCV) infection treated with direct-acting antivirals (DAAs). To identify patients at risk for HCC, we evaluated serum levels of immune mediators before, during, and after DAA treatment of HCV infection. Our study included 13 patients who developed HCC within 18 months after treatment (3 with HCC recurrence and 10 with new HCC) and 10 patients who did not develop HCC (controls), within at least 24 months of treatment (median, 26 months). We identified a set of 12 immune mediators (cytokines, growth factors, and apoptosis markers) whose levels were significantly higher in serum before DAA treatment of patients who eventually developed de novo HCC compared with controls. A panel of 9 cytokines, measured in serum before treatment (MIG, IL22, TRAIL, APRIL, VEGF, IL3, TWEAK, SCF, IL21), identified patients who developed de novo HCC with an area under the receiver operating characteristic curve value higher than 0.8. Further analyses of changes in levels of inflammatory cytokines during DAA treatment also provides important information about HCV-induced carcinogenesis and the effects of DAAs.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Debes JD, van Tilborg M, Groothuismink ZMA, et al. Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting Antivirals. Gastroenterology. 2017. PMID: 29102620. doi:10.1053/j.gastro.2017.10.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。